Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ILMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 1.168B
March 31, 2026 1.155B
December 31, 2025 1.633B
September 30, 2025 1.278B
June 30, 2025 1.155B
March 31, 2025 1.237B
December 31, 2024 1.22B
September 30, 2024 939.00M
June 30, 2024 994.00M
March 31, 2024 1.115B
December 31, 2023 1.054B
September 30, 2023 933.00M
June 30, 2023 1.559B
March 31, 2023 1.518B
December 31, 2022 2.037B
September 30, 2022 1.041B
June 30, 2022 1.327B
March 31, 2022 1.416B
December 31, 2021 1.339B
September 30, 2021 1.265B
June 30, 2021 4.286B
March 31, 2021 4.63B
December 31, 2020 3.472B
September 30, 2020 3.324B
June 30, 2020 3.268B
Date Value
March 31, 2020 3.332B
December 31, 2019 3.414B
September 30, 2019 3.166B
June 30, 2019 3.173B
March 31, 2019 3.615B
December 31, 2018 3.512B
September 30, 2018 3.389B
June 30, 2018 2.512B
March 31, 2018 2.373B
December 31, 2017 2.145B
September 30, 2017 2.041B
June 30, 2017 1.893B
March 31, 2017 1.778B
December 31, 2016 1.559B
September 30, 2016 1.536B
June 30, 2016 1.425B
March 31, 2016 1.343B
December 31, 2015 1.386B
September 30, 2015 1.439B
June 30, 2015 1.510B
March 31, 2015 1.366B
December 31, 2014 1.338B
September 30, 2014 1.271B
June 30, 2014 1.103B
March 31, 2014 1.092B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.758B
Danaher Corp. 4.348B
Thermo Fisher Scientific, Inc. 4.075B
Pacific Biosciences of California, Inc. 236.91M
Bio-Rad Laboratories, Inc. 1.620B